CROX Stock Analysis: Crocs | NASDAQ
Footwear & Accessories | NASDAQ, USA | Market Cap: 6.944m USD | 12M Return: 116.3% | US2270461096 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 162M
EPS Trend: 31.3%
Qual. Beats: 17
Rev. Trend: 38.6%
Qual. Beats: 5
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Crocs, Inc. (NASDAQ: CROX) is a U.S.-based casual lifestyle footwear and accessories company that designs, manufactures, markets, and distributes products for men, women, and kids through two core brands: Crocs and HEYDUDE. Founded in 1999 and headquartered in Broomfield, Colorado, the company has been publicly traded since its 2006 IPO.
The companys product range spans a wide variety of casual footwear categories, including clogs, sandals, loafers, sneakers, slides, slippers, boots, and flats, complemented by accessories such as totes, backpacks, socks, and bag charms. Crocs sells through a diversified omnichannel distribution model that includes wholesalers, branded retail stores, e-commerce sites, third-party marketplaces, outlet stores, and kiosks or store-in-store locations, both domestically and internationally.
Operating within the Consumer Discretionary sectors footwear sub-industry, Crocs pursues a multi-brand strategy, combining its flagship Crocs label with the HEYDUDE brand (acquired in 2022) to broaden its appeal across consumer segments and price points.
- HEYDUDE brand revenue declines on softer demand and integration headwinds
- Vietnam manufacturing exposure raises tariff risk concerns
- Crocs brand faces classic clog saturation in core North American market
| Net Income: 664.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 0.96 > 1.0 |
| NWC/Revenue: 7.65% < 20% (prev 6.86%; Δ 0.78% < -1%) |
| CFO/TA 0.19 > 3% & CFO 813.7m > Net Income 664.4m |
| Net Debt (1.87b) to EBITDA (1.01b): 1.85 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.0m) vs 12m ago -11.18% < -2% |
| Gross Margin: 59.42% > 18% (prev 59.08%; Δ 0.34% > 0.5%) |
| Asset Turnover: 95.59% > 50% (prev 94.72%; Δ 0.87% > 0%) |
| Interest Coverage Ratio: 7.66 > 6 (EBIT TTM 931.5m / Interest Expense TTM 121.6m) |
| A: 0.07 (Total Current Assets 1.03b - Total Current Liabilities 714.0m) / Total Assets 4.28b |
| B: 0.94 (Retained Earnings 4.04b / Total Assets 4.28b) |
| C: 0.22 (EBIT TTM 931.5m / Avg Total Assets 4.29b) |
| D: 0.46 (Book Value of Equity 1.35b / Total Liabilities 2.94b) |
| Altman-Z'' = 5.50 = AAA |
| DSRI: 1.06 (Receivables 383.4m/359.0m, Revenue 4.10b/4.07b) |
| GMI: 0.99 (GM 59.08% / 59.42%) |
| AQI: 0.98 (AQ_t 0.63 / AQ_t-1 0.64) |
| SGI: 1.01 (Revenue 4.10b / 4.07b) |
| TATA: -0.03 (NI 664.4m - CFO 813.7m) / TA 4.28b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of November 10, 2026, the stock is trading at USD 160.23 with a total of 1,177,687 shares traded. Over the past week, the price has changed by +4.64%, over one month by +39.35%, over three months by +15.95% and over the past year by +116.26%.
Current recommended Stop Loss: 153.30 (which is 4.3% or 1.1 ATR below the current price).
Crocs has received a consensus analysts rating of 3.73. Therefore, it is recommended to hold CROX.
- StrongBuy: 5
- Buy: 3
- Hold: 6
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 164.7 | 2.8% |
P/E Trailing = 11.5045
P/E Forward = 9.5602
P/S = 1.6931
P/B = 5.1627
P/EG = 1.3926
Revenue TTM = 4.10b USD
EBIT TTM = 931.5m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 1.29b USD (from longTermDebt, last quarter)
Short Term Debt = 90.8m USD (from shortTermDebt, last quarter)
Debt = 2.04b USD (from shortLongTermDebtTotal, last quarter) + Leases 374.1m
Net Debt = 1.87b USD (calculated: Debt 2.04b - CCE 163.5m)
Enterprise Value = 8.82b USD (6.94b + Debt 2.04b - CCE 163.5m)
Interest Coverage Ratio = 7.66 (Ebit TTM 931.5m / Interest Expense TTM 121.6m)
EV/FCF = 11.69x (Enterprise Value 8.82b / FCF TTM 754.0m)
FCF Yield = 8.55% (FCF TTM 754.0m / Enterprise Value 8.82b)
FCF Margin = 18.38% (FCF TTM 754.0m / Revenue TTM 4.10b)
Net Margin = 16.20% (Net Income TTM 664.4m / Revenue TTM 4.10b)
Gross Margin = 59.42% ((Revenue TTM 4.10b - Cost of Revenue TTM 1.66b) / Revenue TTM)
Gross Margin QoQ = 66.16% (prev 59.41%)
Tobins Q-Ratio = 2.06 (Enterprise Value 8.82b / Total Assets 4.28b)
Interest Expense / Debt = 5.97% (Interest Expense 121.6m / Debt 2.04b)
Taxrate = 21.60% (183.1m / 847.4m)
NOPAT = 730.3m (EBIT 931.5m * (1 - 21.60%))
Current Ratio = 1.44 (Total Current Assets 1.03b / Total Current Liabilities 714.0m)
Debt / Equity = 1.51 (Debt 2.04b / totalStockholderEquity, last quarter 1.35b)
Debt / EBITDA = 1.85 (Net Debt 1.87b / EBITDA 1.01b)
Debt / FCF = 2.49 (Net Debt 1.87b / FCF TTM 754.0m)
Total Stockholder Equity = 1.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.49% (Net Income 664.4m / Total Assets 4.28b)
RoE = 48.76% (Net Income TTM 664.4m / Total Stockholder Equity 1.36b)
RoCE = 35.13% (EBIT 931.5m / Capital Employed (Equity 1.36b + L.T.Debt 1.29b))
RoIC = 20.90% (NOPAT 730.3m / Invested Capital 3.49b)
WACC = 8.35% (E(6.94b)/V(8.98b) * Re(9.43%) + D(2.04b)/V(8.98b) * Rd(5.97%) * (1-Tc(0.22)))
Discount Rate = 9.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.61 | Cagr: -9.99%
[DCF] Terminal Value 76.10% ; FCFF base≈738.9m ; Y1≈774.4m ; Y5≈893.7m
[DCF] Fair Price = 260.2 (EV 13.8b - Net Debt 1.87b = Equity 11.9b / Shares 45.7m; r=8.35% [WACC]; 5y FCF grow 5.27% → 2.50% )
EPS Correlation: 31.32 | EPS CAGR: 1.23% | SUE: 2.58 | # QB: 17
Revenue Correlation: 38.63 | Revenue CAGR: 0.50% | SUE: 3.45 | # QB: 5
EPS current Quarter (2027-03-31): EPS=3.43 | Chg30d=+6.34% | Revisions=+50% | Analysts=9
EPS current Year (2026-12-31): EPS=14.63 | Chg30d=+4.90% | Revisions=+82% | GrowthEPS=+17.0% | GrowthRev=+3.4%
EPS next Year (2027-12-31): EPS=16.01 | Chg30d=+7.12% | Revisions=+81% | GrowthEPS=+9.4% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: +86% (up=33, down=1)